Search results
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 4 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WSB Radio· 1 day agoWASHINGTON — (AP) — Government advisers Wednesday said it’s time to update the recipe for the...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
Will there be a new Covid vaccine in the fall?
NBC Universal via AOL· 1 day agoNovavax uses a protein-based vaccine, which takes longer to manufacture than the mRNA-based vaccines made by Pfizer and Moderna. All ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
TV 7&4 Traverse City· 18 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Arizona Daily Sun· 4 days agoModerna and partner Merck & Co said on Monday their cancer vaccine in combination with blockbuster...
US approves Moderna's RSV vaccine for older adults
Alaska Superstation· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
FDA panel recommends new COVID-19 vaccine formula for fall
United Press International via Yahoo News· 13 hours agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoThe U.S. Food and Drug Administration approved Moderna’s vaccine to protect against respiratory syncytial virus, or RSV, a common virus that is among the...
Moderna wins second product approval with RSV vaccine
Market Watch· 7 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...